Biotech news
Biotech
SCOTUS ignored Fed Circ cases and so-called Wands factors in reaching enablement decision | Pivotal question left unanswered | New guidance ‘provides clarity’ and reinforces status quo on enablement decisions. 11 January 2024
Biotech
Mark Hatch-Miller, who led the trial team at Susman for Globus, tells Sarah Speight how this spinal implant patent dispute, brought by a Johns Hopkins neurosurgeon, was a “heavy lift”. 21 December 2023
Pharma
CureVac suffers a blow following a favourable earlier opinion delivered by the German Federal Patent Court | Decision invalidates a patent related to mRNA tech. 21 December 2023
Biotech
Medical device company wins eight-day jury trial in spinal implant patent dispute | Johns Hopkins neurosurgeon claimed Globus Medical directly infringed multiple patents in US | Susman Godfrey | Fish & Richardson. 19 December 2023
Biotech
Biotech firm agrees licence deal days after its gene editing treatment gets landmark FDA approval | Patents owned by the Broad Institute protect technology sold via Editas Medicines. 14 December 2023
Biotech
Emcure fends off COVID-19 trade secrets suit in Washington | A US biotech had inked a short-lived deal with Indian generic pharma company’s subsidiary. 5 December 2023
Biotech
Patent applications need to offer the full picture when it comes to scientific research, finds Marisa Woutersen at LSPN Europe. 30 November 2023
Americas
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares. 28 November 2023
Pharma
The European Patent Office hands a win to BioNTech and Pfizer in coronavirus vaccine dispute | US biotech plans to appeal decision affecting mRNA patent. 23 November 2023
Biotech
Recent clashes over patents covering modified guide RNAs have exposed different approaches from the US and Europe—and new complications for the field, says Claire Irvine of HGF. 21 November 2023